Table 4.
Bivariate Analysis: IR and OR Patients with Early Complications
| Variables | IR | P Value | OR | P Value |
|---|---|---|---|---|
| n=23 (%) | n=32 (%) | |||
| Age | 0.314 | 0.161 | ||
| Median (min–max) | 60 (22–78) | 60 (34–80) | ||
| Age | 0.199 | 0.21 | ||
| Mean ± SD | 53.9 ± 14.9 | 60.8 ± 11.4 | ||
| Gender | 0.297 | 0.020 | ||
| Male | 7 (7) | 4 (6) | ||
| Female | 16 (11) | 28 (17) | ||
| Tip | 1.000 | 0.069 | ||
| RA/CAJ/LowSVC | 19 (10) | 4 (7) | ||
| Other | 4 (10) | 28 (16) | ||
| Diagnosis | 0.803 | 0.264 | ||
| Solid | 18 (9) | 201 (87) | ||
| Hematological | 4 (13) | 1 (50) | ||
| Other* | 1 (10) | 5 (100) | ||
| Indication | 1.000 | 0.618 | ||
| Chemotherapy | 22 (10) | 202 (86) | ||
| Other† | 1 (9) | 5 (100) | ||
| In vs Out | 0.014 | 0.231 | ||
| Out | 19 (8) | 195 (86) | ||
| In | 4 (36) | 12 (100) | ||
| MD vs NP | 0.924 | 0.250 | ||
| MD | 8 (10) | 163 (85.3) | ||
| NP | 15 (9.5) | 44 (92) | ||
| Comorbidity | ||||
| Pulmonary | 0.032 | 0.160 | ||
| No | 14 (7) | 182 (88) | ||
| Yes | 9 (18) | 25 (78) | ||
| Cardiovascular | 0.110 | 0.215 | ||
| No | 15 (13) | 105 (84) | ||
| Yes | 8 (7) | 102 (89.5) | ||
| Renal | 0.749 | 0.602 | ||
| No | 21 (10) | 201 (87) | ||
| Yes | 2 (7) | 6 (75) | ||
| Hepatic | 1.000 | 0.598 | ||
| No | 22 (10) | 200 (86) | ||
| Yes | 1 (8) | 0 |
*
Other: sickle cell anemia, cystic fibrosis, Fabry disease, Crohn’s disease, total parenteral nutrition, hypomagnesia
†
Other: magnesium infusions, iron infusions, lab draws, poor venous access